Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge
- 1 December 2007
- Vol. 25 (51) , 8562-8573
- https://doi.org/10.1016/j.vaccine.2007.10.017
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (01-AI-25464, 19-AI-05719)
- Bavarian Nordic
This publication has 18 references indexed in Scilit:
- Immunological Memory after Exposure to Variola Virus, Monkeypox Virus, and Vaccinia VirusThe Journal of Infectious Diseases, 2007
- Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulinVirology, 2005
- Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccineVaccine, 2005
- Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox VirusJournal of Virology, 2005
- Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypoxNature, 2004
- Improved Assay To Detect Neutralizing Antibody following Vaccination with Diluted or Undiluted Vaccinia (Dryvax) VaccineJournal of Clinical Microbiology, 2003
- Primary Induction of Human CD8+Cytotoxic T Lymphocytes and Interferon‐γ–Producing T Cells after Smallpox VaccinationThe Journal of Infectious Diseases, 2002
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Standard Percutaneous Revaccination of Children Who Received Primary Percutaneous VaccinationThe Journal of Infectious Diseases, 1977
- MVA-Stufenimpfung gegen PockenDeutsche Medizinische Wochenschrift (1946), 1974